Útgefið vísindaefni varðandi krabbamein
... tengt Krabbameinsskránni

Leitarvél:

2008: Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, Risch HA, Eyfjord JE, Hopper JL, Southey MC, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Go
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
Br J Cancer. 2008 Apr 22;98(8):1457-66. Epub 2008 Mar 18. Erratum in: Br J Cancer. 2008 Jun 17;98(12):2015. Passini, B [corrected to Pasini, B].; Baili P, Micheli A, De Angelis R, Weir HK, Francisci S, Santaquilani M,
Life tables for world-wide comparison of relative survival for cancer (CONCORD study).
Tumori. 2008 Sep-Oct;94(5):658-68.; Chuang SC, Hashibe M, Scelo G, Brewster DH, Pukkala E, Friis S, Tracey E, Weiderpass E, Hemminki K, Tamaro S, Chia KS, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Dresler CM, Boffetta P, Brennan P.
Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1543-9.; Chuang SC, Scelo G, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, Hemminki K, Weiderpass E, Pukkala E, Tracey E, Friis S, Pompe-Kirn V, Brewster DH, Martos C, Chia KS, Boffetta P, Brennan P, Hashibe M.
Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries.
Int J Cancer. 2008 Nov 15;123(10):2390-6.; Jónasson JG.
[Screening for breast cancer reduces mortality]
Laeknabladid. 2008 Feb;94(2):99. Icelandic.; Kapeu AS, Luostarinen T, Jellum E, Dillner J, Hakama M, Koskela P, Lenner P, Löve A, Mahlamaki E, Thoresen S, Tryggvadóttir L, Wadell G, Youngman L, Lehtinen M.
Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks.
Am J Epidemiol. 2009 Feb 15;169(4):480-8. Epub 2008 Dec 13.; Maule M, Scélo G, Pastore G, Brennan P, Hemminki K, Pukkala E, Weiderpass E, Olsen JH, Tracey E, McBride ML, Brewster DH, Pompe-Kirn V, Tonita JM, Kliewer EV, Chia KS, Jonasson JG, Martos C, Magnani C, Boffetta P.
Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study.
Eur J Cancer. 2008 Apr;44(6):830-9. Epub 2008 Mar 10.; Nøhr B, Munk C, Tryggvadottir L, Sparén P, Tran TN, Nygård M, Skare GB, Dasbach E, Liaw KL, Kjaer SK.
Awareness of human papillomavirus in a cohort of nearly 70,000 women from four Nordic countries.
Acta Obstet Gynecol Scand. 2008;87(10):1048-54.; Robins G, Crabtree JE, Bailey A, Forman D; EUROGAST Study Group.
International variation in Helicobacter pylori infection and rates of oesophageal cancer.
Eur J Cancer. 2008 Mar;44(5):726-32. Epub 2008 Feb 14.; Sant M, Allemani C, De Angelis R, Carbone A, de Sanjosè S, Gianni AM, Giraldo P, Marchesi F, Marcos-Gragera R, Martos-Jiménez C, Maynadié M, Raphael M, Berrino
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States.
Eur J Cancer. 2008 Mar;44(4):579-87. Epub 2008 Jan 31.; Sveinsson OA, Orvar KB, Birgisson S, Agnarsdottir M, Jonasson JG.
Clinical features of microscopic colitis in a nationwide follow-up study in Iceland.
Scand J Gastroenterology 2008; 43: 955-960.; Vidarsdottir H, Gunnarsdottir HK, Olafsdottir EJ, Olafsdottir GH, Pukkala E, Tryggvadottir L.
Cancer risk by education in Iceland; a census-based cohort study.
Acta Oncol. 2008;47(3):385-90.; Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM, Paci E; EUROCARE Working Group.
Survival in patients with uveal melanoma in Europe.
Arch Ophthalmol. 2008 Oct;126(10):1413-8.; ↑ Fara efst í listann
2007: Bodvarsdottir SK, Hilmarsdottir H, Birgisdottir V, Steinarsdottir M, Jonasson JG, Eyfjord JE.
Aurora-A amplification associated with BRCA2 mutation in breast tumours.
Cancer Lett. 2007 Apr 8;248(1):96-102. Epub 2006 Jul 24.; Bodvarsdóttir SK, Steinarsdóttir M, Hilmarsdóttir H, Jónasson JG, Eyfjörd JE.
MYC amplification and TERT expression in breast tumor progression.
Cancer Genet Cytogenet. 2007 Jul 15;176(2):93-9.; Gabe R, Tryggvadóttir L, Sigfússon BF, Olafsdóttir GH, Sigurdsson K, Duffy SW.
A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death.A
cta Radiol. 2007 Nov;48(9):948-55.; Jonasson JG, Tryggvadótir L. Iceland. Cancer Incidence in Iceland (1998-2002). In: Curado. M.P., Edwards, B., Shin. H.R., Storm. H., Ferlay. J., Heanue. M. and Boyle. P.,
eds (2007) Cancer Incidence in Five Continents, Vol. IX.
IARC Scientific Publications No. 160, Lyon, IARC.; Kjaer SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E, Liaw KL, Nygård J, Nygård M.
The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries.
J Infect Dis. 2007 Nov 15;196(10):1447-54. Epub 2007 Oct 31.; Kvåle R, Auvinen A, Adami HO, Klint A, Hernes E, Møller B, Pukkala E, Storm HH, Tryggvadottir L, Tretli S, Wahlqvist R, Weiderpass E, Bray F.
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
J Natl Cancer Inst. 2007 Dec 19;99(24):1881-7. Epub 2007 Dec 11.; Maule M, Scélo G, Merletti F, Brennan P, Hemminki K, Tracey E, Pukkala E, Weiderpass E, Olsen JH, McBride ML, Brewster DH, Pompe-Kirn V, Kliewer EV, Chia KS, Tonita JM, Martos C, Jonasson JG, Pastore G, Boffetta P. (JNCI) 2007; 99:790-800.
Cumulative incidence of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
J Natl Cancer Inst; Maule M, Scélo G, Pastore G, Brennan P, Hemminki K, Tracey E, Sankila R, Weiderpass E, Olsen JH, McBride ML, Brewster DH, Pompe-Kirn V, Kliewer EV, Chia KS, Tonita JM, Martos C, Jonasson JG, Merletti F, Boffetta P.
Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
J Natl Cancer Inst. 2007 May 16;99(10):790-800.; Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, Jellum E, Jousilahti P, Knekt P, Koskela P, Kyyrönen PP, Lenner P, Luostarinen T, Löve A, Ogmundsdóttir H, Stattin P, Tenkanen L, Tryggvadóttir L, Virtamo J, Wadell G, Widell A, Lehti
Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.
Acta Oncol. 2007;46(3):286-307.; Richiardi L, Scélo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Kee-Seng C, Jonasson JG, Martos C, Brennan P.
Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
Int J Cancer. 2007 Feb 1;120(3):623-31.; Riska A, Pukkala E, Scélo G, Mellemkjaer L, Hemminki K, Weiderpass E, McBride ML, Pompe-Kirn V, Tracey E, Brewster DH, Kliewer EV, Tonita JM, Kee-Seng C, Jonasson JG, Martos C, Boffetta P, Brennan P.
Second primary malignancies in females with primary fallopian tube cancer.
Int J Cancer. 2007 May 1;120(9):2047-51.; Rubio CA, Petersson F, Höög A, Jónasson JG, Nesi G, Chandanos E, Lindblad M.
Further studies on serrated neoplasias of the cardia: a review and case report.
Anticancer Res. 2007 Nov-Dec;27(6C):4431-4.; Scélo G, Boffetta P, Autier P, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Chia KS, Jonasson JG, Martos C, Giblin M, Brennan P.
Associations between ocular melanoma and other primary cancers: an international population-based study.
Int J Cancer. 2007 Jan 1;120(1):152-9.; Scélo G, Boffetta P, Corbex M, Chia KS, Hemminki K, Friis S, Pukkala E, Weiderpass E, McBride ML, Tracey E, Brewster DH, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Brennan P.
Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries.
Cancer Causes Control. 2007 Apr;18(3):269-78. Epub 2007 Jan 19.; Tryggvadóttir L, Vidarsdóttir L, Thorgeirsson T, Jonasson JG, Olafsdóttir EJ, Olafsdóttir GH, Rafnar T, Thorlacius S, Jonsson E, Eyfjord JE, Tulinius H.
Prostate cancer progression and survival in BRCA2 mutation carriers.
J Natl Cancer Inst. 2007 Jun 20;99(12):929-35. Epub 2007 Jun 12.; Tryggvadóttir L, Vidarsdóttir L, Thorgeirsson T, Jonasson JG, Olafsdóttir EJ, Olafsdóttir GH, Rafnar T, Thorlacius S, Jonsson E, Eyfjord JE, Tulinius H.
Prostate cancer progression and survival in BRCA2 mutation carriers.
J Natl Cancer Inst. 2007 Jun 20;99(12):929-35. Epub 2007 Jun 12.; Tryggvason G, Kristmundsson T, Orvar K, Jónasson JG, Magnússon MK, Gíslason HG.
Clinical study on gastrointestinal stromal tumors (GIST) in Iceland, 1990-2003.
Dig Dis Sci. 2007 Sep;52(9):2249-53. Epub 2007 Apr 10.; Tuohimaa P, Pukkala E, Scélo G, Olsen JH, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Kliewer EV, Pompe-Kirn V, McBride ML, Martos C, Chia KS, Tonita JM, Jonasson JG, Boffetta P, Brennan P.
Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
Eur J Cancer. 2007 Jul;43(11):1701-12. Epub 2007 May 30.; ↑ Fara efst í listann
2006: Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG, Eyfjord JE.
Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
Breast Cancer Res. 2006;8(4):R38.; Bodvarsdottir SK, Hilmarsdottir H, Birgisdottir V, Steinarsdottir M, Jonasson JG, Eyfjord JE.
Aurora-A amplification associated with BRCA2 mutation in breast tumours.
Cancer Lett. 2007 Apr 8;248(1):96-102. Epub 2006 Jul 24.; Bretthauer M, Ekbom A, Malila N, Stefánsson T, Fischer A, Hof G, Weiderpass E, Tretli S, Tryggvadóttir L, Storm H, Holten I, Adam HO.
[Screening for colorectal cancer. Collaboration among politicians and scientists is necessary]
Laeknabladid. 2006 Jul-Aug;92(7-8):521-4. Icelandic.; Colonna M, Grande E, Jónasson JG, Eurocare Working Group.
Variation in relative survival of thyroid cancers in Europe: results from the analysis on 21 countries over the period 1983-1994 (EUROCARE-3 study).
Eur J Cancer. 2006 Oct;42(15):2598-608. Epub 2006 Sep 18.; Eldon BJ, Thorlacius S, Jonsson T, Jonasson JG, Kjartansson J, Bodvarsson S, Steingrimsson E, Rafnar T.
A population-based study on the familial aggregation of cutaneous malignant melanoma in Iceland.
Eur J Cancer. 2006 May;42(7):922-6. Epub 2006 Mar 10.; Jónasson JG.
[Epidemiologic research on cancer. The importance of population-based studies]
Laeknabladid. 2006 May;92(5):362-3. Icelandic.; Jonsson E, Sigbjarnarson HP, Tomasson J, Benediktsdottir KR, Tryggvadottir L, Hrafnkelsson J, Olafsdottir EJ, Tulinius H, Jonasson JG.
Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Scand J Urol Nephrol. 2006;40(4):265-71.; Jonsson E, Sigbjarnarson HP, Tomasson J, Benediktsdottir KR, Tryggvadottir L, Hrafnkelsson J, Olafsdottir EJ, Tulinius H, Jonasson JG.
Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Scand J Urol Nephrol. 2006;40(4):265-71.; Mellemkjaer L, Friis S, Olsen JH, Scélo G, Hemminki K, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, Kee-Seng C, Pompe-Kirn V, Martos C, Jonasson JG, Boffetta P, Brennan P.
Risk of second cancer among women with breast cancer.
Int J Cancer. 2006 May 1;118(9):2285-92.; Oddsson S, Kristvinsson H, Jónasson JG, Torfason B, Guðbjartsson T.
Desmoid æxli í brjóstvegg mikilvæg mismunagreining við illkynja mein. Sjúkratilfelli.
Læknablaðið 2006; 92: 777-780.; Sandeep TC, Strachan MW, Reynolds RM, Brewster DH, Scélo G, Pukkala E, Hemminki K, Anderson A, Tracey E, Friis S, McBride ML, Kee-Seng C, Pompe-Kirn V, Kliewer EV, Tonita JM, Jonasson JG, Martos C, Boffetta P, Brennan P.
Second primary cancers in thyroid cancer patients: a multinational record linkage study.
J Clin Endocrinol Metab. 2006 May;91(5):1819-25. Epub 2006 Feb 14.; Scélo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Andersen A, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Chia KS, Jonasson JG, Martos C, Colin D, Brennan P.
Associations between small intestine cancer and other primary cancers: an international population-based study.
Int J Cancer. 2006 Jan 1;118(1):189-96.; Shen M, Boffetta P, Olsen JH, Andersen A, Hemminki K, Pukkala E, Tracey E, Brewster DH, McBride ML, Pompe-Kirn V, Kliewer EV, Tonita JM, Chia KS, Martos C, Jonasson JG, Colin D, Scélo G, Brennan P.
A pooled analysis of second primary pancreatic cancer.
Am J Epidemiol. 2006 Mar 15;163(6):502-11. Epub 2006 Jan 18.; Sigurdsson V, Fridriksdottir AJF, Kjartansson JK, Jonasson JG, Steinarsdottir M, Petersen W, Ogmundsdottir HM, Gudjonsson Th.
Human breast microvascular endothelial cells retain phenotypic traits in long-term finite life span in culture.
In Vitro Cell Dev Biol 2006; 42: 332-340.; Svahn-Tapper G, Garwicz S, Anderson H, Shamsaldin A, De Vathaire F, Olsen JH, Døllner H, Hertz H, Jonmundsson G, Langmark F, Lanning M, Sankila R, Tulinius H, Möller T.
Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: a population-based case-control study in the five Nordic countries.
Acta Oncol. 2006;45(4):438-48.; Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjörd JE.
Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
J Natl Cancer Inst. 2006 Jan 18;98(2):116-22.; Vidarsdottir L, Bodvarsdottir SK, Hilmarsdottir H, Tryggvadottir L, Eyfjord JE.
Breast cancer risk associated with AURKA 91T -->A polymorphism in relation to BRCA mutations.
Cancer Lett. 2007 Jun 8;250(2):206-12. Epub 2006 Nov 17.; Vidarsson H, Steinarsdóttir M, Jónasson JG, Júlíusdóttir H, Hauksdóttir H, Hilmarsdóttir H, Halldórsdóttir K, Ogmundsdóttir HM.
Effect of hypoxia and TP53 mutation status and cytogenetics of normal and malignant mammary epithelium.
Cancer Genet Cytogenet. 2006 Mar;165(2):144-50.; Vietharsdóttir H, Moeller PH, Jóhannsson J, Jónasson JG.
[Anal cancer in Iceland 1987-2003. A population based study]
Laeknabladid. 2006 May;92(5):365-72. Icelandic.; ↑ Fara efst í listann
2005: Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H,
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.
J Med Genet. 2005 Jul;42(7):602-3.; Brennan P, Scélo G, Hemminki K, Mellemkjaer L, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, Seow A, Pompe-Kirn V, Martos C, Jonasson JG, Colin D, Boffetta P.
Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma.
Br J Cancer. 2005 Jul 11;93(1):159-66.; Hemminki K, Scélo G, Boffetta P, Mellemkjaer L, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride M, Kliewer EV, Chia KS, Pompe-Kirn V, Martos C, Jonasson JG, Li X, Brennan P.
Second primary malignancies in patients with male breast cancer.
Br J Cancer. 2005 Apr 11;92(7):1288-92.; Lehtinen M, Ogmundsdottir HM, Bloigu A, Hakulinen T, Hemminki E, Gudnadottir M, Kjartansdottir A, Paavonen J, Pukkala E, Tulinius H, Lehtinen T, Koskela P.
Associations between three types of maternal bacterial infection and risk of leukemia in the offspring.
Am J Epidemiol. 2005 Oct 1;162(7):662-7. Epub 2005 Aug 24.; Møller B, Weedon-Fekjaer H, Hakulinen T, Tryggvadóttir L, Storm HH, Talbäck M, Haldorsen T.
The influence of mammographic screening on national trends in breast cancer incidence.
Eur J Cancer Prev. 2005 Apr;14(2):117-28.; Ogmundsdóttir HM, Haraldsdóttirm V, Jóhannesson GM, Olafsdóttir G, Bjarnadóttir K, Sigvaldason H, Tulinius H.
Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families.
Haematologica. 2005 Jan;90(1):66-71.; Rubio CA, Jonasson JG, Nesi G, Mandai M, Pisano R, King A, Owen D.
Extensive intestinal metaplasia in gastric carcinoma and in other lesions requiring surgery. A study of 3421 gastrectomy specimens from dwellers of the Atlantic and Pacific basins.
J Clin Pathol 2005; Dec 58(12): 1271-1277.; Rubio CA, Mandai K, Jónasson JG, King A, Nesi G, Kogan Z, Pisano R, Miller M, Owen D.
Gastric glassy cells: a study of 3202 gastrectomy specimens from dwellers of the Atlantic and Pacific basins.
J Environ Pathol Toxicol Oncol. 2005;24(4):281-9.; Rubio CA, Nesi G, Zampi GC, de Ruiz PA, Jesserun J, Jonasson JG, Hojman R, Kogan Z, Antonioli D, Miller L, Hirota T, Itabashi T, Mandai M, Kitagawa T, Sugano H, Kato Y, King A, Pisano R, Owen D.
Gastric ciliated metaplasia. A study of 3406 gastrectomy specimens from dwellers of the Atlantic and Pacific Basins.
J Clin Pathol 2005;58(6):605-610.; Svensson E, Møller B, Tretli S, Barlow L, Engholm G, Pukkala E, Rahu M, Tryggvadóttir L, Langmark F, Grotmol T.
Early life events and later risk of colorectal cancer: age-period-cohort modelling in the Nordic countries and Estonia.
Cancer Causes Control. 2005 Apr;16(3):215-23.; Tryggvason G, Gíslason HG, Magnússon MK, Jónasson JG.
Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study.
Int J Cancer. 2005 Nov 1;117(2):289-93.; Vidarsdóttir H, Möller PH, Tryggvason G, Kjartansson S, Jónasson JG.
[Gastrointestinal Stromal Tumour (GIST). Case report]
Laeknabladid. 2005 Feb;91(2):177-9. Icelandic.; ↑ Fara efst í listann
2004: Armannsdóttir B, Tryggvadóttir L, Jónasson JG, Olafsdóttir EJ, Guðmundsson JA.
[Use of hormone replacement therapy by Icelandic women in the years 1996-2001.]
Laeknabladid. 2004 Jun;90(6):471-477. Icelandic.; Langner I, Blettner M, Gundestrup M, Storm H, Aspholm R, Auvinen A, Pukkala E, Hammer GP, Zeeb H, Hrafnkelsson J, Rafnsson V, Tulinius H, De Angelis G, Verdecchia A, Haldorsen T, Tveten U, Eliasch H, Hammar N, Linnersjö A.
Cosmic radiation and cancer mortality among airline pilots: results from a European cohort study (ESCAPE).
Radiat Environ Biophys. 2004 Feb;42(4):247-56. Epub 2003 Nov 28.; Petursdottir TE, Thorsteinsdottir U, Jonasson JG, Moller PH, Huiping C, Bjornsson J, Egilsson V, Imreh S, Ingvarsson S.
Interstitial deletions including chromosome 3 common eliminated region 1 (C3CER1) prevail in human solid tumors from 10 different tissues.
Genes Chromosomes Cancer. 2004 Nov;41(3):232-42.; Rafnsson V, Hrafnkelsson J, Tulinius H, Sigurgeirsson B, Olafsson JH.
Risk factors for malignant melanoma in an Icelandic population sample.
Prev Med. 2004 Aug;39(2):247-52.; Steinarsdóttir M, Jónasson JG, Vidarsson H, Júlíusdóttir H, Hauksdóttir H, Ogmundsdóttir HM.
Cytogenetic changes in nonmalignant breast tissue.
Genes Chromosomes Cancer. 2004 Sep;41(1):47-55.; Tryggvason G, Blöndal S, Goldin RD, Albrechtsen J, Björnsson J, Jónasson JG.
Epithelioid angiomyolipoma of the liver: case report and review of the literature.
APMIS. 2004 Sep;112(9):612-6. Review.; ↑ Fara efst í listann
2003: Antoniou A, Pharoah PD, Narod S et al.
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies.
Am J Hum Genet. 2003 May;72(5):1117-30.; Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Ee
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
Am J Hum Genet. 2003 May;72(5):1117-30. Epub 2003 Apr 3. Erratum in: Am J Hum Genet. 2003 Sep;73(3):709.; Blettner M, Zeeb H, Auvinen A, Ballard TJ, Caldora M, Eliasch H, Gundestrup M, Haldorsen T, Hammar N, Hammer GP, Irvine D, Langner I, Paridou A, Pukkala E, Rafnsson V, Storm H, Tulinius H, Tveten U,
Tzonou Mortality from cancer and other causes among male airline cockpit crew in Europe.
Int J Cancer. 2003 Oct 10;106(6):946-52.; Eldon BJ, Jonsson E, Tomasson J, Tryggvadottir L, Tulinius H.
Familial risk of prostate cancer in Iceland.
BJU Int 2003 Dec;92(9):915-9.; Gudmundsdottir K, Thorlacius S, Jonasson JG, Sigfusson BF, Tryggvadottir L, Eyfjord JE.
CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status.
Br J Cancer 2003;88(6):933-936.; Gudmundsdottir T, Tryggvadottir L, Allende M, Mast TC, Briem H, Sigurdsson K.
Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial.
Acta Obstet Gynecol Scand. 2003 Apr;82(4):345-50.; Halldorsdottir AM, Sigurdardottir M, Jonasson JG, Oddsdottir M, Magnusson J, Lee JR, Goldenring J.
Spasmolytic polypeptid expressing metaplasia (SPEM) associated with gastric cancer in Iceland.
Dig Dis Sci 2003;48:431-441.; Lehtinen M, Koskela P, Ogmundsdottir HM, Bloigu A, Dillner J, Gudnadottir M, Hakulinen T, Kjartansdottir A, Kvarnung M, Pukkala E, Tulinius H, Lehtinen T.
Maternal herpesvirus infections and risk of lymphoblastic leukemia in the offspring.
Am J Epidemiol 2003;58:207-213.; Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, Holub J, Storm HH, Forman D, Quinn M, Aareleid T, Sankila R, Hakulinen T, Faivre J, Ziegler H, Tryggvadottir L, Zanetti R, Dalmas M, Visser O, Langmark F, Bielska-Lasota M, Wronkowski
European health systems and cancer care.
Ann Oncol. 2003;14Suppl 5:V41-V60.; Mikaelsdottir EK, Benediktsdottir KR, Olafsdottir K, Arnadottir Th, Ragnarsson GB, Olafsson K, Sigurdsson K, Kristinsdottir GS, Imsland AK, Rafnar Þ.
HPV subtypes and immunological parameters of cervical cancer in Iceland during two time periods, 1958-1960 and 1995-1996.
Gynaecol Oncol. 2003;89:22-30.; Moller T, Anderson H, Aareleid T, Hakulinen T, Storm H, Tryggvadottir L, Corazziari I, Mugno E.
Cancer prevalence in Northern Europe: the EUROPREVAL study.
Ann Oncol. 2003 Jun;14(6):946-57.; Rafnsson V, Hrafnkelsson J, Tulinius H, Sigurgeirsson B, Olafsson JH.
Risk factors for cutaneous malignant melanoma among aircrews and a random sample of the population.
Occup Environ Med. 2003 Nov;60(11):815-20.; Rafnsson V, Sulem P, Tulinius H, Hrafnkelsson J.
Breast cancer risk in airline cabin attendants: a nested case-control study in Iceland.
Occup Environ Med. 2003 Nov;60(11):807-9.; Tryggvadottir L, Olafsdottir EJ, Gudlaugsdottir S, Thorlacius S, Jonasson JG, Tulinius H, Eyfjord JE.
BRCA2 mutation carriers, reproductive factors and breast cancer risk.
Breast Cancer Research 2003,5:R121-R128.; ↑ Fara efst í listann
2002: Agnarsdottir M, Gunnlaugsson O, Orvar K, Birgisson S, Cariglia N, Thorgeirsson Th, Jonasson JG.
Collagenous colitis and lymphocytic colitis in Iceland.
Dig Dis Sci 2002;7(5):1122-1128.; Baffoe-Bonnie AB, Kiemeney LA, Beaty TH, Bailey-Wilson JE, Schnell AH, Sigvaldason H, Olafsdottir GH, Tryggvadottir L, Tulinius H.
Segregation analysis of 389 Icelandic pedigrees with breast and prostate cancer.
Genet Epidemiol. 2002 Nov;23(4):349-63.; Hamajima N, Hirose K, Tajima K, et al.
Collaborative Group on Hormonal Factors in Breast Cancer. Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease.
Br J Cancer. 2002;87(11):1234-45.; Huiping C, Kristjansdottir S, Bergthorsson JTh, Jonasson JG, Magnusson J, Egilsson V, Ingvarsson S.
High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer.
Eur J Cancer 2002;38:728-735.; Imsland AK, Eldon BJ, Arinbjarnarson S, Egilsson V, Tulinius H, Tryggvadottir L, Arngrimsson R, Magnusson J.
Genetic epidemiologic aspects of gastric cancer in Iceland.
J Am Coll Surg 2002 Aug;195(2):181-6; discussion 186-7.; Jonasson JG et al. Iceland. In: Parkin DM, et al.ed.
Cancer Incidence in Five Continents, Volume VIII.
IARC Scientific Publication NO. 155. International Agency for Research on Cancer. Lyon, France 2002.; Jonasson L, Hallgrimsson J, Jonsson Th, Moller PH, Theodors A, Sigvaldason H, Jonasson JG.
Ristilkrabbamein á Íslandi 1955-1989. Rannsókn á lifun með tilliti til meinafræðilegra þátta. [Carcinoma of the colon in Iceland 1955-1989. An investigation of survival according to various pathological parameters.]
Læknablaðið (Icelandic Medical J) 2002;88:479-487.; Moller B, Fekjaer H, Hakulinen T, Tryggvadottir L, Storm HH, Talback M, Haldorsen T.
Prediction of cancer incidence in the Nordic countries up to the year 2020.
Eur J Cancer Prev. 2002 Jun;11 Suppl 1:S1-96. Review.; O'Neill BP, Blondal H, Yang P, Olafsdottir GH, Sigvaldason H, Jenkins RB, Kimmel DW, Scheithauer BW, Rocca WA, Bjornsson J, Tulinius H.
Risk of cancer among relatives of patients with glioma.
Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):921-4.; Ogmundsdottir HM, Haraldsdottir V, Johannesson G, Olafsdottir G, Bjarnadottir K, Sigvaldason H, Tulinius H.
Monoclonal gammopathy in Iceland: a population-based registry and follow-up.
Br J Haematol 2002;118,1,166-73.; Petursdottir ThE, Hafsteinsdottir SH, Jonasson JG, Moller PH, Thorsteinsdottir U, Huiping C, Egilsson V, Ingvarsson S.
Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patients.
Anticancer Research 2002;22:3205-3212.; Tryggvadottir L, Tulinius H, Eyfjord JE, Sigurvinsson T.
Breast cancer risk factors and age at diagnosis: an Icelandic cohort study.
Int J Cancer 2002;98,4:604-8.; Tulinius H, Olafsdottir GH, Sigvaldason H, Arason A, Barkardottir RB, Egilsson V, Ogmundsdottir HM, Tryggvadottir L, Gudlaugsdottir S, Eyfjord JE.
The effect of a single BRCA2 mutation on cancer in Iceland.
J Med Genet 2002;39,7:457-62.; Winther JF, Sankila R, Boice JD Jr, Tulinius H, Bautz A, Barlow L, Glattre E, Langmark F, Moller T, Mulvihill JJ, Olafsdottir GH, Ritvanen A, Olsen JH.
Cancer hos søstkende til born med cancer [Cancer amongst sisters and brothers of children affected with cancer.]
Ugeskr Laeger 2002;164,23:3073-9.; ↑ Fara efst í listann
2001: Falck Winther J, Sankila R, Boice Jr. JD, Tulinius H, Bautz A, Barlow L, Glattre E, Langmark F, Moller T, Mulvihill JJ, Olafsdottir GH.
Cancer in siblings of children with cancer in the Nordic Countries: a population-based cohort study.
Lancet 2001;358:711-17.; Gudmundsdottir K, Tryggvadottir L, Eyfjord JE.
GSTM1, GSTT1 and GSTP1 genotypes in relation to breast cancer risk and frerquency of mutations in the p53 gene.
Cancer Epidemiology, Biomarkers & Prevention. 2001;10:1169-1173.; Helicobacter and Cancer Collaborative Group.
Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts.
GUT 2001;49:347-53.; Hrafnkelsson J, Tulinius H, Jonasson JG, Olafsdottir G, Sigvaldason H.
Familial non-medullary thyroid cancer in Iceland.
J Med Genetics 2001;38:189-90.; Huiping C, Kristjansdottir S, Jonasson JG, Magnusson J, Egilsson V, Ingvarsson S.
Alterations of E-cadherin and beta-catenin in gastric cancer.
BMC Cancer 2001;1:16.; Ingvarsson S, Sigbjornsdottir BI, Huiping C, Jonasson JG, Agnarsson BA.
Alterations of the FHIT gene in breast cancer: Association with tumour progression and patient survival.
Cancer Detection and Prevention 2001;25(3):292-298.; Jonasson L, Hallgrimsson JH, Magnusson J, Jonsson Th, Theodors A, Jonasson JG.
Ristilkrabbamein á Íslandi 1955-1989. Meinafræðileg athugun. [Carcinoma of the colon in Iceland 1955-1989. A study on pathology.]
Læknablaðið (Icelandic Medical J) 2001;87:111-117.; Moller TR, Garwicz S, Barlow L, Winther JF, Glattre E, Olafsdottir G, Olsen JH, Perfekt R, Ritvanen A, Sankila R, Tulinius H.
Decreasing late mortality among 5-year survivors of cancer in childhood and adolescence: A population-based study in the Nordic Countries.
J Clin Oncol 2001;19:3173-81.; Palsson R, Jonasson JG, Kristjansson M, Bodvarsson A, Goldin RD, Cox DW, Olafsson S.
Fulminent Hepatic Failure due to Wilsons Disease. A rare presentation of a patient homozygous for the Icelandic mutation.
Eur J Gastroent and Hepat. 2001;13(4):433-436.; Rafnsson V, Tulinius H, Jonasson JG, Hrafnkelsson J.
Risk of breast cancer in female flight attendants: a population-based study (Iceland).
Cancer Causes and Control 2001:12:95-101.; Ragnarsdottir B, Jonasson JG, Tulinius H, Olafsson S.
Lifrarfrumukrabbamein á Íslandi. [Hepatocellular carcinoma in Iceland.]
Læknablaðið (Icelandic Medical J) 2001;87:527-31.; Rubio C, Kato Y, Jonasson JG.
Protruding and Non-protruding Adenomas of the Stomach.
Anticancer Research 2001;21:3037-3040.; Rubio C, Kato Y, Jonasson JG.
Protruding and Non-protruding Adenomas of the Stomach: A micrometric classification.
GI Cancer 2001;3(5):323-327.; Rubio CA, Jonasson JG, Filipe I, Cabanne AM, Hojman R, Kogan Z, Nesi G, Amorosi A, Zampi G, Klimstra D.
Gastric Carcinoma of the Intestinal Type Concur with Distant Changes in the Gastric Mucosa. A Multicentric Study in the Atlantic Basin.
Anticancer Research 2001;21(1B):813-818.; Tryggvadottir L, Tulinius H, Eyfjord JE, Sigurvinsson T.
Breastfeeding and reduced risk of breast cancer in an Icelandic cohort study.
Am J Epidemiol 2001;154:37-42.; Tryggvadottir L, Tulinius H, Eyfjord JE.
Breastfeeding and reduced risk of breast cancer in an Icelandic cohort study. The authors reply.
Am J Epidemiol 2001;154:976-7.; Tulinius H, Ogmundsdottir HM, Kristinsson KG, Sigvaldason H, Sigvaldadottir E, Kristjansdottir G, Sigfusson N.
Helicobacter pylori antibodies and gastric cancer in Iceland. - The decline in IgG antibody level is a risk factor.
APMIS 2001;109:835-41.; ↑ Fara efst í listann
2000: Asgeirsson KS, Jonasson JG, Tryggvadottir L, Olafsdottir K, Sigurgeirsdottir JR, Ingvarsson S, Ogmundsdottir HM.
Altered expression of E-cadherin in breast cancer: patterns, mechanisms and clinical significance.
Eur J Cancer 2000;36:1098-1106.; Baffoe-Bonnie A, Beaty TH, Bailey-Wilson JE, Kiemeney L, Sigvaldason H, Olafsdottir G, Tryggvadottir L, Tulinius H.
Genetic Epidemiology of Breast Cancer: Segregation Analysis of 389 Icelandic Pedigrees.
Genet Epidemiol. 2000;18:81-94.; Birgisson H, Tryggvadottir, Tulinius H.
Áhrif meðgöngu á lifun kvenna er greinst hafa áður með brjóstakrabbamein. [The effect of pregnancy on the survival of women previously diagnosed with breast cancer.]
Læknablaðið (Icelandic Medical J) 2000;86:495-8.; Botterweck AAM, Schouten LJ, Volovics A, Dorant E, van den Brandt PA.
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries.
Int J Epidemiol 2000;29:645-54.; Garwicz S, Anderson H, Olsen JH, Dollner H, Hertz H, Jonmundsson G, Langmark F, Lanning M, Moller T, Sankila R, Tulinius H.
Second malignant neoplasms after cancer in childhood and adolescence: A population-based case-control study in the 5 Nordic countries.
Int J Cancer 2000;88,672-8.; Gudlaugsdottir S, Sigurdardottir V, Snorradottir M, Jonasson JG, Ogmundsdottir HM, Eyfjord JE.
P53 mutation analysis in benign and malignant breast lesions. Using needle rinses from fine needle aspitrations.
Diagnostic Cytopathology 2000;22(5):268-274.; Gudmundsdottir I, Jonasson JG, Sigurdsson H, Olafsdottir K, Tryggvadottir L, Ogmundsdottir HM.
Altered expression of HLA class I antigens in breast cancer: Association with prognosis.
Int J Cancer 2000;89:500-505.; Halldorsdottir AM, Agnarsson BA, Tulinius H, Bjarnadottir K, Jonasson JG.
Lifrarmeinvörp af óþekktum uppruna. [Liver metastases of unknown origin.]
Læknablaðið (Icelandic Medical J) 2000;86:661-5.; Hrafnkelsson J, Tulinius H, Kjeld M, Sigvaldason H, Jonasson JG.
Serum thyroglobulin as a risk factor for thyroid carcinoma.
Acta Oncologica 2000;38,8:973-7.; Huiping C, Jonasson JG, Agnarsson BA, Sigbjornsdottir BI, Huebner K, Ingvarsson S.
Analysis of the FHIT gene in lobular breast cancer.
Eur J Cancer 2000;36:1552-1557.; Johannsdottir JTh, Jonasson JG, Bergthorsson JTh, Amundadottir LT, Magnusson J, Egilsson V, Ingvarsson S.
The effect of mismatch repair deficiency on tumorigenesis; Microsatillite instability affecting genes containing short repeated sequences.
Int J Oncol 2000;16:133-139.; Rafnsson V, Hrafnkelsson J, Tulinius H.
Incidence of cancer among commercial airline pilots.
Occup Environ Med 2000;57,3:175-9.; Rafnsson V, Hrafnkelsson J, Tulinius H.
Letter to the editor: Re: Incidence of cancer among comercial airline pilots.
Occup Environ Med 2000;57:843.; Ragnarsson GB, Mikaelsdottir EK, Vidarsson H, Jonasson JG, Olafsdottir K, Kristjansdottir K, Kjartansson J, Ogmundsdottir HM, Rafnar Th.
Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
Br J Cancer 2000;83(12)1715-1721.; Sigurdsson S, Anamthawat-Jonsson K, Bodvarsdottir SK, Steinarsdottir M, Valgardsdottir R, Jonasson JG, Ogmundsdottir HM, Eyfjord JE.
p53 abnormalities and chromosomal abnormalities in the same tumour cells.
Cancer Genetics and Cytogenetics 2000;121:150-155.; Tryggvadottir L. Cancer registries and genetic screening. In: Sankila R, Demaret E, Hakama M, Lynge E, Schouten LJ and Parkin DM (eds).
Evaluation and monitoring of screening programes.
European Commision, Europe Against Cancer Programme, Brussels-Luxembourg, 2000.; ↑ Fara efst í listann
1999: Birgisson H, Einarsson GV, Jonasson JG.
Metanephric adenoma. A case report.
Scand. J. Urol. Nephrol. 1999;33:340-344.; Gatta G, Capocaccia R, Hakulinen T, Sant M, Verdecchia A, De Angelis G, Micheli A, Berrino F &the EUROCARE Working Group.
Variation in survival for invasive cervical cancer among European women, 1978-89.
Cancer Causes and Control 1999;10:575-581.; Huiping C, Sigurgeirsdottir JR, Jonasson JG, Eiriksdottir G, Johannsdottir JT, Egilsson V, Ingvarsson S.
Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.
Br J Cancer 1999;81(7):1103-1110.; Johannsdottir JTh, Bergthorsson JTh, Gretarsdottir S, Ragnarsson G, Jonasson JG, Egilsson V, Ingvarsson S.
Replication error in colorectal carcinoma: Association with loss of heterozygosity at mismatch repair loci and clinicopathologic variables.
Anticancer Research 1999;19:1821-1826.; Ogmundsdottir HM, Sveinsdottir S, Sigfusson A, Jonasson JG, Agnarsson BA.
Enhanced B-cell survival in familial macroglobulinaemia with increased expression of Bcl-2.
Journal of Clin Experim Immunol 1999;117:252-260.; Ragnarsson G, Eiriksdottir G, Johannsdottir JTh, Jonasson JG, Egilsson V, Ingvarsson S.
Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival.
Br J Cancer 1999;79(9/10):1468-1474.; Sigurdsson K.
The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
Acta Obstet Gynaecol Scand 1999;78:478-485.; Sigurdsson K.
Trends in cervical intra-epithelial neoplasia in Iceland through 1995.
Acta Obstet Gynaecol Scand. 1999;78:486-492.; Tulinius H, Sigvaldason H, Olafsdottir G, Tryggvadottir L, Bjarnadottir K.
Breast cancer incidence and familality in Iceland during 75 Years from 1921 to 1995.
J Med Genet 1999;36:103-107.; Webb PM, Crabtree JE, Forman D, The Eurogast Study Group.
Gastric Cancer, Cytoxin-Asociated Gene A-Positive Helicobacter pylori, and Serum Pepsinogens: An International Study.
Gastroenterology 1999;116:269-276.; ↑ Fara efst í listann
1998: Agnarsson BA, Jonasson JG, Bjornsdottir IB, Barkardottir RB, Egilsson V, Sigurdsson H.
Inherited BRCA2 mutation associated with high grade breast cancer.
Breast Cancer Research & Treatment 1998;47:121-127.; Asgeirsson KS, Olafsdottir K, Jonasson JG, Ogmundsdottir HM.
The effects of IL-6 on cell adhaesion and E-cadherin expression in breast cancer.
Cytokine 1998;10:720-728.; Aspelund G, Jonsson T, Jonasson JG, Guðjonsson H.
Heilkenni Gardners. Sjúkratilfelli mánaðarins. [Gardners syndrome. A case report.]
Læknablaðið (Icelandic Medical J) 1998;84:935-938.; Eiriksdottir G, Johannesdottir G, Ingvarsson S, Bjornsdottir IB, Jonasson JG, Agnarsson BA, Gudmundsson J, Bergthorsson JÞ, Egilsson V, Sigurdsson H, Barkardottir RB.
Mapping Loss of Heterozygosity at Chromosome 13q: Loss at 13q12-q13 is Associated with Breast Tumour Progression and Poor Prognosis.
Eur J Cancer 1998;34:2076-2081.; Eliasson JH, Tryggvadottir L, Tulinius H, Gudmundsson JA.
Hormónameðferð kvenna á Íslandi. [Hormonal replacement therapy in women in Iceland.]
Læknablaðið (Icelandic Medical J) 1998;84:25-31.; Engeland A, Haldorsen T, Dickman P, Hakulinen T, Moller TR, Storm HH, Tulinius H.
Relative Survival of Cancer Patients. A Comparison between Denmark and the other Nordic Countries.
Acta Oncol 1998, Vol. 37;1:49-59.; Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gay
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium.
Am J Hum Genet 1998;62:676.; Gretarsdottir S, Thorlacius S, Valgardsdottir R, Gudlaugsdottir S, Sigurdsson S, Steinarsdottir M, Jonasson JG, Anamthawat-Jonsson K, Eyfjord JE.
BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.
Cancer Research - Advances in brief 1998;58:859-862.; Hjalgrim H, Tulinius H, Dalberg J, Hardarson S, Frich M, Melbye M.
High incidence of classical KaposiŽs sarcoma in Iceland and the Faroe Islands.
Br J Cancer 1998; 77(7),1190-1193.; Ingvarsson S, Geirsdottir EK, Johannesdottir G, Sigbjornsdottir BI, Eiriksdottir G, Ragnarsson G, Agnarsson BA, Gudmundsson J, Jonasson JG, Sigurdsson A, Egilsson V, Barkardottir RB.
High incidence of loss of heterozygosity in breast tumours from carriers of the 999del5 BRCA2 mutation.
Cancer Research 1998;58:4421-4425.; Sankila R, Olsen JH, Anderson H, Garwicz S, Glattre E, Hertz H, Langmark F, Lanning M, Moller T, Tulinius H.
Risk of Cancer among Offspring of Childhood-Cancer Survivors.
N Engl J Med 1998;338(19):1339.; Sigurdsson K, Sigurdardottir B, Steinsson S, Benediktsdottir KR, Sigurvinsson T, Sigvaldason H.
Survival and prognostic factors of endometrial cancer patients in Iceland 1964-1985: Can attendance at population-based pap-smear screening affect survival?
Int J Cancer 1998;79:166-174.; Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjord JE.
Population-based study of risk of breast cancer in carriers of BRCA2 mutation.
Lancet 1998;352:1337-1339.; ↑ Fara efst í listann
1997: Breinholt V, Dragsted LO, Alexander J, Afthan G, Andersen C, Knudsen I, Tulinius H.
Antitumourigenic dithiolethiones.
TemaNord 1997;613:1-73.; Hjalgrim H, Frisch M, Pukkala E, Tulinius H, Ekbom A, Dictor M, Langmark F, Hardarson S, Melbye M.
Risk of second cancers in classical KaposiŽs sarcoma.
Int J Cancer 1997;73:840-3.; Kiemeney LA, Moret NC, Witjes JA, Schoenberg MP, Tulinius H.
Familial transitional cell carcinoma among the population of Iceland.
J Urology 1997;157:1649-51.; Kristjansson AK, Eiriksdottir G, Ragnarsson G, Sigurdsson A, Gudmundsson J, Barkardottir RB, Jonasson JG, Egilsson V, Ingvarsson S.
Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables.
Anticancer Research 1997;17:93-98.; Sigurdsson K, Arnadottir Th, Snorradottir M, Benediktsdottir KR, Saemundsson H.
Human papillomavirus (HPV) in an Icelandic population: the role of HPV DNA testing based on hybrid capture and PCR assays among women with screen-detected abnormal pap smears.
Int J Cancer. 1997;72:446-452.; Sigurdsson S, Thorlacius S, Tomasson J, Tryggvadottir L, Benediktsdottir KR, Eyfjord JE, Jonsson E.
BRCA2 mutation in Icelandic prostate cancer patients.
J Mol Med 1997;75:758-763.; Steinarsdottir M, Jonasson JG, Petursdottir I, Sigurdsson H, Ogmundsdottir HM.
A comparison of Cytogenetic Studies and Flow Cytometry in Breast Carcinomas.
Cytometry 1997;28:323-328.; Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H, Eyfjord JE.
Study of a single BRCA2 mutation with high carrier frequency in a small population.
Am J Hum Genet. 1997;60:1079-84.; Thorvaldsson SE, Tulinius H, Bjarnason O.
Þyngd skjaldkirtils í Íslendingum. Niðurstöður úr 197 réttarkrufningum. [The weight of the thyroid gland in Icelanders. Results from 197 forensic autopsies.]
Læknablaðið (Icelandic Medical J) 1997;83:748-50.; Tryggvadottir L, Tulinius H, Gudmundsdottir GB.
Oral contraceptive use at a young age and the risk of breast cancer; an Icelandic, population-based cohort study of the effect of birth year.
Br J Cancer 1997;75:139-43.; Tulinius H, Bjarnadottir K, Bjarnason O, Olafsdottir GH.
Iceland in: Parkin DM, Wheelan SL, Ferlay, J, Reymond L, Young J, eds. Cancer Incidence in Five Continents, Vol VII.
IARC Scientific Publication Nol 143. Lyon 1997.; Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L.
Risk Factors for Malignant Diseases: A Cohort Study on a Population of 22.946 Icelanders.
Cancer Epidemiol. Biomark. Prev 1997;6:863-73.; Tulinius H.
Íslenskar rannsóknir á krabbameinum í brjóstum. Ritstjórnargrein. [Icelandic research on breast cancer. Editorial.]
Læknablaðið (Icelandic Medical J) 1997;83:7.; Valgardsdottir R, Tryggvadottir L, Steinarsdottir M, Olafsdottir K, Jonasdottir S, Jonasson JG, Ogmundsdottir HM, Eyfjord JE.
Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis.
APMIS 1997;105:121-130.; Webb PM, Bates CJ, Palli D, Forman D and the Eurogast Study Group.
Gastric Cancer, Gastritis and Plasma Vitamin C: Results from an International Correlation and Cross-Sectional Study.
Int J Cancer 1997;73:684-9.; ↑ Fara efst í listann
1996: Agnarsson BA, Sigurdsson H, Jonasson JG, Kristjansdottir S.
Flæðigreining krabbameina. [Flow cytometric analysis of human malignancies.]
Læknablaðið (Icelandic Medical J) 1996;82:131-136.; de Pedro-Cuesta J, Gudmundsson G, Abraira V, Gudmundsson G, Love A, Tulinius H, Veiga J et al.
Whooping cough and ParkinsonŽs disease.
Int J of Epidemiol 1996;25:1301-11.; Gretarsdottir S, Tryggvadottir L, Jonasson JG, Sigurdsson H, Olafsdottir K, Agnarsson BA, Ogmundsdottir HM, Eyfjord JE.
TP53 mutation analysis on breast carcinomas; a study of paraffin embedded archival material.
Br J Cancer 1996;74:555-561.; Gudlaugsdottir S, Sigurdsson H, Agnarsson BA, Jonasson JG, Kristjansdottir S, Baldursson G, Bjornsson S, Sveinsson Th.
DNA flæðigreining eykur nákvæmni við mat á horfum sjúklinga með brjóstakrabbamein. [DNA flow cytometry is a useful prognostic guide in the treatment of breast cancer.]
Læknablaðið (Icelandic Medical J) 1996;82:138-147.; Jonasson JG, Agnarsson BA, Thorlacius S, Eyfjord JE, Tulinius H.
Male breast cancer in Iceland.
Int J Cancer 1996;65:446-9.; Manfredsdottir VF, Tryggvadottir, L, Tulinius H, Gudmundsdottir GB.
Notkunarmynstur getnaðarvarnarpillunnar á Íslandi 1965 til 1989. [The use of oral contraceptives in Iceland 1965-1989.]
Læknablaðið (Icelandic Medical J) 1996;82:460-4.; Ragnarsson G, Sigurdsson A, Eiriksdottir G, Barkardottir RB, Jonasson JG, Ingvarsson S.
Loss of heterozygosity at chromosome 1p in human breast cancer: association with high S-phase, reduced patient survival and deletions at other chromosome regions.
Int J Oncol 1996;9:731-736.; Sankila R, Garwicz S, Olsen JH, Dollner G, Hertz H, Kreuger A, Langmark F, Lanning M, Moller T, Tulinius H.
Risk of Subsequent Malignant Neoplasms Among 1,641 HodgkinsŽs Disease Patients Diagnosed in Childhood and Adolescence: A Population-Based Cohort Study in the Five Nordic Countries.
J Clin Oncol 1996; 14:1442-46.; Sigurdsson K, Arnadottir Th, Snorradottir M, Benediktsdottir KR, Saemundsson H.
Human papillomavirus (HPV) in an Icelandic population: correlation of HPV DNA to cyto- and histopathologic lesions and evaluation of treatment strategies.
Int J Gynaecol Cancer. 1996;6:175-182.; Thorlacius S, Olafsdottir GH, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ogmundsdottir HM, Eyfjord JE.
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.
Nature Genet 1996;13:117-119.; Tretli S, Engeland, Haldorsen T, Hakulinen T, Horte LG, Luostarinen T, Schou G, Sigvaldason H, Storm HH, Tulinius H, Vaittinen P.
Prostate Cancer - Look to Denmark?
J Nat Cancer Inst 1996;88:128.; ↑ Fara efst í listann
1995: Bragadottir G, Eiriksdottir G, Sigurdsson A, Barkardottir RB, Guðmundsson J, Jonasson JG, Ingvarsson S.
Loss of heterozygosity at chromosome 6q correlates with tumor progression and patient survival.
Int J Oncol 1995;7:871-876.; de Pedro-Cuesta J, Petersen IJ, Stawiarz L, Gudmundsson G, Gudmundsson G, Almazán J, Tulinius H, Johansson H.
High levodopa use in peiodically time-clustered, Icelandic birth cohorts. A vestige of Parkinsonism etiology?
Acta Neurol Scand 1995;91:79-88.; Eiriksdottir G, Sigurdsson A, Jonasson JG, Agnarsson BA, Sigurdsson H, Gudmundsson J, Bergthorsson JTh, Barkardottir RB, Egilsson V, Ingvarsson S.
Loss of heterozygosity on chromosome 9 in human breast cancer: association with clinical variables and genetic changes at other chromosome regions.
Int J Cancer (Pred. Oncol) 1995;64:378-382.; Engeland A, Haldorsen T, Tretli S, Hakulinen T, Horte LG, Luostarinen T, Schou G, Sigvaldason H, Storm HH, Tulinius H, Vaittinen P.
Prediction of cancer incidence in the Nordic Countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries.
APMIS 1995;103(Suppl.49):1-163.; Sigurdsson K.
Quality in cervical cancer screening. The Icelandic experience 1964-1993.
Eur J Cancer. 1995;31A:728-734.; Thorlacius S, Thorgilsson B, Bjornsson J, Tryggvadottir L, Borresen AL, Ogmundsdottir HM, Eyfjord JE.
TP53 mutations and abnormal TP53 protein staining in breast carcinomas related to prognosis.
Eur J Cancer 1995;31A:1856-1861.; Thorlacius S, Tryggvadottir L, Olafsdottir GH, Jonasson JG, Ogmundsdottir HM, Tulinius H, Eyfjord JE.
Linkage to BRCA2 region in hereditary male breast cancer.
The Lancet 1995;346:544-45.; Tulinius H.
Impact of genetics on cancer.
In: Parr E, Næss A, Rossland T: Kreftepidemiologi. Oslo 1995;56-9.; ↑ Fara efst í listann
1994: Hrafnkelsson J, Jonasson JG.
Skjaldkirtilskrabbamein á Íslandi. Faraldsfræði og þættir sem hafa áhrif á horfur sjúklinga með sérstöku tilliti til flæðigreiningar. [Thyroid cancer in Iceland. Epidemiology and prognostic factors with special emphasis on the results of nuclear DNA-analy
Læknablaðið (Icelandic Medical J) 1994;80:452-463.; Jonasson JG, Hrafnkelsson J.
Nuclear DNA-analysis and prognosis in carcinoma of the thyroid gland - A nationwide study in Iceland on carcinomas diagnosed 1955-1990.
Virchows Archiv An Int J of Pathology 1994;425(4):349-355.; Jonasson L, Hallgrimsson J, Sigvaldason H, Olafsdottir G, Tulinius H.
Gastric cancer in Iceland: a retrospective study of resected gastric specimens in a high-risk country during 30 years (1960-1989).
Int J Cancer 1994;57:793-798.; The Eurogast Study Group.
The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates.
Gastroenterology 1994;107:1335-44.; The Eurogast Study Group.
O6-Methylguanine in blood leucocyte DNA: an association with the geographic prevalence of gastric cancer and with low levels of serum pepsinogen A, a marker of severe chronic atrophic gastritis.
Carcinogenesis 1994;15:1815-20.; Tryggvadottir L, Tulinius H, Larusdottir M.
A decline and a halt in mean age at menarche in Iceland.
Annals of Human Biology 1994;21:179-86.; Tulinius H, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Bjarnadottir K.
Neoplastic diseases in families of breast cancer patients.
J Med Genet 1994;31:618-21.; ↑ Fara efst í listann
1993: Ducatman BS, Wang HH, Jonasson JG, Hogan CL, Antonioli DA.
Tubal metaplasia: A cytologic study with comparison to other neoplastic and non-neoplastic conditions of the endocervix.
Diagnostic Cytopathology 1993;9:98-105.; Engeland A, Haldorsen T, Tretli S, Hakulinen T, Horte LG, Luostarinen T, Magnus K, Schou G, Sigvaldason H, Storm HH, Tulinius H, Vaittinen P.
Prediction of cancer incidence in the Nordic Countries.
APMIS 1993;Suppl. No. 38, 101:1-124.; Hrafnkelsson J, Sigvaldason H, Tulinius H.
Nýgengi krabbameina og dánartíðni krabbameinssjúklinga á Íslandi síðustu 35 árin. [Incidence and mortality of cancer patients in Iceland during 35 years.]
Læknablaðið (Icelandic Medical Journal) 1993;79:185-90.; Nielsen GP, Jonasson JG, Agnarsson BA, Isaksson HJ.
Flow cytometric DNA analysis of adenocarcinomas of the vermiform appendix.
APMIS 1993;101:811-814.; Olsen JH, Garwicz S, Hertz H, Jonmundsson G, Langmark F, Lanning M, Lie SO, Moe PJ, Moller T, Sankila R, Tulinius H.
Second malignant neoplasms after cancer in childhood or adolescence.
Br Med J 1993;307:1030-6.; Strube M, Dragsted LO, Larsen JC, Knodsen I, Alexander J, Alfthan G, Anderson C, Tulinius H.
Naturally occuring antitumourignes.
I. Plant phenols. Nordiske Seminar- og Arbejdsrapporter 1993:605. The Nordic Council of Ministers. Copenhagen, Denmark. 1-222.; The Eurocgast Study Group.
An international association between Helicobacter pylori infections and gastric cancer.
Lancet 1993;341:1359-62.; The Eurogast Study Group.
Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations.
Gut 1993;34:1672-6.; Thorlacius S, Borresen AL, Eyfjord JE.
Somatic p53 mutations in human breast carcinomas in an Icelandic population: A prognostic factor.
Cancer Research 1993;53:1637-1641.; Tryggvadottir L, Birgisson H, Jonasson JG, Tulinius H.
Upplýsingar um dánarmein á dánarvottorðum. [Information from death certificates on causes of death.]
Læknablaðið (Icelandic Medical J) 1993;79:313-20.; ↑ Fara efst í listann
1992: Bjornsson J, Jonasson JG, Nielsen GP.
Áreiðanleiki dánarvottorða. [Reliability of death certificates.]
Læknablaðið (Icelandic Medical J) 1992;78; 181-185.; Darby SC, Olsen JH, Doll R, Thakrar B, de Nully Brown P, Storm HH, Barlow L, Langmark F, Teppo L, Tulinius H.
Trends in Childhood Leukemia in the Nordic Countries in Relation to Fallout From Atmospheric Nuclear Weapons Testing.
Br Med J 1992;304:1005-9.; Eyfjord JE, Thorlacius S.
Genetic changes in breast carcinomas in an Icelandic population.
Pharmacogenetics 1992;2:309-316.; Jonasson JG, Wang HH, Antonioli DA, Ducatman BS.
Tubal metaplasia of the uterine cervix: A prevalence study in patients with gynecological pathological findings.
Int J Gynaecol Pathol 1992;11:89-95.; Jonasson JG, Wang HH, Porter DH, Tyagi G, Ducatman BS.
Image-directed percutaneous biopsy. A comparison of cytologic and histolocic findings.
Cancer 1992;70(8):2187-2191.; Jonasson L, Hallgrimsson, Sigvaldason H, Olafsdottir G, Tulinius H.
Magakrabbamein í Íslendingum 1955-1984: Afturskyggn rannsókn á meingerð og staðsetningju æxla í mögum teknum með skurðaðgerð. [A retrospective study of morphology and topography of tumors surgically removed from stomach.]
Læknablaðið (Icelandic Medical J) 1992;78:395-404.; Nikulasson S, Hallgrimsson J, Tulinius H, Sigvaldason H, Olafsdottir G.
Tumours in Iceland. 16. Malignant tumours of the stomach.
APMIS 1992;100:930-41.; Petursdottir V, Jonasson JG, Hrafnkelsson J.
Tumours in Iceland. 17. Malignant tumours of the oesophagus. Histological classifications and epidemiological considerations.
APMIS 1992;100: 942-948.; Thorvaldsson SE, Tulinius H, Bjarnason O.
Latent thyroid carcinoma in Iceland at autopsy.
Path. Res. Pract. 1992;188:747-50.; Tulinius H, Egilsson V, Olafsdottir GH, Sigvaldason H.
Risk of prostate, ovarial and endometrial cancer among relatives of breast cancer patients.
Br Med J 1992;305:855-7.; Tulinius H, Egilsson V, Olafsdottir GH, Sigvaldason H.
Risque de cancer de la prostate, de l'ovaire et de l'endométre en cas d'antécédent familial de cancer du sein.
le Journal International de Médecine 28 oct.1992, No. 151. 25-8.; Tulinius H, Sigvaldason H, Olafsdottir G, Tryggvadottir L.
Epidemiology of breast cancer in families in Iceland.
J Med Genet 1992;29:158-64.; Tulinius H, Storm HH, Pukkala E, Andersen A, Ericsson J.
Cancer in the Nordic Countries 1981-86.
A Joint Publication of the Five Nordic Cancer Registries. APMIS 1992; Suppl. No. 31, vol. 100, 1-194.; Tulinius H. Iceland. In: Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds.
Cancer Incidence in Five Continents Vol VI.
IARC, Lyon. 1992:618-21.; ↑ Fara efst í listann
1991: Arnar DO, Theodors A, Isaksson HJ, Gunnlaugsson GH, Tulinius H, Johannsson H, Kjartansson S.
Cancer of the pancreas in Iceland. An epidemiological and clinical study 1974-1985.
Scan J Gastroenterol 1991;26:724-30.; Hakama M, Magnus K, Pettersson F, Storm H, Tulinius H.
Effect of organized screening on the risk of cervical cancer in the Nordic countries. In: Miller AB, Champerlain J, Day NE, Hakama M, Prorok PC, (eds). Cancer Screening.
International Union Against Cancer, Cambridge University Press, 1991, p. 153-62.; Jonasson JG, Bjornsson J.
Autopsy. Clinicopathological concordance and imaging techniques. In: Riboli E & Delendi M, (eds.) Autopsy in Epidemiology and Medical Research.
Lyon International Agency for Research on Cancer, p 91-98. IARC 1991.; Nielsen GP, Bjornsson J, Jonasson JG.
The Accuracy of Death Certificates. Implications for healt statistics.
Virchows Arch A Pathol Anat 1991;419:143-46.; Nielsen GP, Theodors A, Tulinius H, Sigvaldason H.
Gallblöðrutaka og krabbamein í ristli og endaþarmi á Íslandi. [Cholecystectomies and cancer of colon and rectum in Iceland.]
Læknablaðið (Icelandic Medical J) 1991;77:211-6.; Nielsen GP, Theodors A, Tulinius H, Sigvaldason H.
Cholecystectomy and colorectal carcinoma. A total population historical prospective study.
The Am J Gastroenterol 1991;86:1486-90.; Sigurdsson K, Adalsteinsson S, Ragnarsson J.
Trends in cervical and breast cancer in Iceland. A statistical evaluation of trends in incidence and mortality for the period 1955-1989, their relation to screening and prediction to the year 2000.
Int J Cancer 1991;48:523-528.; Sigurdsson K, Benediktsdottir KR, Snorradottir M, Saemundsson H, Olafsson JH, Einarsson GV.
Cervical intraepithelial neoplasia and koilocytotic lesions of the lower uterine genitalia in an Icelandic population.
Int J Gynaecol Cancer. 1991;1:49-57.; Sigurdsson K, Hrafnkelsson J, Geirsson G, Gudmundsson J, Salvarsdottir A.
Screening as a prognostic factor in cervical cancer: Analysis of survival and prognostic factors based on Icelandic population data.
Gynecol Onc 1991;43:64-70.; Wang HH, Jonasson JG, Ducatman BS.
Brush cytology of the upper gastrointestinal tract: Obsolete or not?
Acta Cytol 1991;35(2):195-198.; ↑ Fara efst í listann
1990: Adami H-O, Adams G, Boyle P, Ewertz M, Lee NC, Lund E, Miller AB, Olsson H, Steel M, Trichopoulos D, Tulinius H.
Breast Cancer Etiology. Chapter II in: Pontén J, Larsson L-G, eds. Breast cancer, critical overviews.
Int J Cancer 1990; Suppl. 5, 22-39.; Ewertz M, Duffy SW, Adami H, Kvåle G, Lund E, Meirik O, Mellemgaard A, Soini I, Tulinius H.
Age at first birth, parity and risk of breast cancer: A meta-analysis of 8 studies from the Nordic Countries.
Int J Cancer 1990;46:597-603.; Hrafnkelsson J, Sigvaldason H, Tulinius H, Sveinsson Th.
Krabbameinsáhætta hjá börnum sem fengu geislameðferð vegan góðkynja sjúkdóma fyrir 1950. [Cancer risk in children treated by x-rays for benign diseases before 1950.]
Læknablaðið (Icelandic Medical J) 1990;76:131-6.; Jonasson JG, Ducatman BS, Wang HH.
The cell block for body cavity fluids: Do the results justify the cost?
Modern Pathol 1990;3(6):667-670.; Sigfusson B, Hallgrimsson P.
Breast cancer screening in Iceland: Preliminary results. Recent Results in Cancer Research 119.
Springer-Verlag, Berlin-Heidelberg, 1990, 94-99.; Tulinius H, Sigvaldason H, Hrafnkelsson J, Olafsdottir G, Tryggvadottir L, Sigurdsson K.
Reproductive factors and breast cancer risk in Iceland. A second cohort study.
Int J Cancer 1990;46:972-5.; Tulinius H, Sigvaldason H, Olafsdottir G.
Left and right sided breast cancer.
Path. Res. Pract. 1990;186:92-4.; ↑ Fara efst í listann
1989: Benediktsdottir KR, Jonasson JG, Hallgrimsson J. Tumours in Iceland. 12.
Malignant tumours of the corpus of the uterus. A histological classification, epidemiological considerations and survival.
APMIS 1989;97:781-786.; Hrafnkelsson J, Tulinius H, Jonasson JG, Olafsdottir G, Sigvaldason H.
Papillary thyroid carcinoma in Iceland. A study of the occurrence in families and the coexistence of other primary tumours.
Acta Oncol 1989;28:785-8.; Jonasson JG, Hrafnkelsson J, Bjornsson J. Tumours in Iceland. 11.
Malignant tumours of the thyroid gland. A histological classification and epidemiological considerations.
APMIS 1989; 97:625-630.; Sigurdsson K, Adalsteinsson S, Tulinius H, Ragnarsson J.
The value of screening as an approach to cervical cancer control in Iceland, 1964-1986.
Int J Cancer 1989;43:1-5.; Tulinius H.
Current status of cancer registration in Europe.
In: Boyle P, Muir CS, Grundmann E, Eds. Cancer Mapping. Recent Results in Cancer Research 114, 70-4. Springer-Verlag, Berlin 1989.; ↑ Fara efst í listann
1988: Arnthorsson G, Tulinius H, Egilsson V, Sigvaldason H, Magnusson B, Thorarinsson H.
Gastric cancer after gastrectomy.
Int J Cancer 1988;42:365-7.; Hrafnkelsson J, Jonasson JG, Sigurdsson G, Sigvaldason H, Tulinius H.
Thyroid cancer in Iceland 1955-1984.
Acta Endocrinol 1988;118:566-72.; Hrafnkelsson J, Sigvaldason H, Ingimarsson GS, Tulinius H.
Spá um fjölda krabbameina á Íslandi árið 2000 byggð á upplýsingum úr krabbameinsskrá frá 1957 til 1986. [Predictions for year 2000 of frequency of cancer in Iceland based on cancer registration 1957-1986.]
Læknablaðið (Icelandic Medical J) 1988;74:371-7.; Hrafnkelsson J, Staal O, Enestrom S, Jonasson JG, Bjornsson J, Olafsdottir K, Nordenskjold B.
Cellular DNA pattern, S-phase frequency and survival in papillary thyroid cancer.
Acta Oncol 1988;27:329-333.; Jensen OM, Carstensen B, Glattre E, Malker B, Pukkala E, Tulinius H.
Atlas of Cancer Incidence in the Nordic Countries. A Collaborative Study of the five Nordic Cancer Registries.
Helsinki, Nordic Cancer Union, l988.; Rafnsson V, Johannesdottir SG, Oddsson H, Benediktsson H, Tulinius H, Magnusson G.
Mortality and cancer incidence of marine engineers and mechanists in Iceland.
Scand J Work Environ Health 1988;14:197-200.; Tryggvadottir L, Tulinius H, Robertson J McD.
Familial and sporadic breast cancer cases in Iceland: A comparison with respect to ABO blood groups and the risk of bilateral cancer of the breast.
Int J Cancer 1988;42:499-501.; Tulinius H, Bjarnason O, Sigvaldason H, Bjarnadottir G, Olafsdottir G.
Tumours in Iceland. 10. Malignant tumours of the female breast. A histological classification, laterality, survival and epidemiological considerations.
APMIS 1988;96:229-38.; ↑ Fara efst í listann
1987: Bjarnason O, Tulinius H.
Tumours in Iceland 9. Malignant Tumours of the Ovary. A Histological Classification, Epidemiological Considerations and Survival.
Acta Pathol Microbiol Immunol Scand Sect A 1987;95:185-92.; Mulvihill JJ, Tulinius H.
Cancer Ecogenetics: Studying Genetic and Environment Interactions through Epidemiology.
International Journal of Epidemiology 1987;16,3:337-40.; Tulinius H, Bjarnason O, Sigvaldsson H, Bjarnadottir G, Olafsdottir GH, Bjarnason T.
Iceland.
In: Muir C, Waterhouse J, Mack T, Powell J, Whelan S, eds.: Cancer Incidence in Five Continents Volume V. IARC Scientific Publication NO. 88. International Agency for Research on Cancer, Lyon 1987, p. 553-555.; ↑ Fara efst í listann
1986: Bjornsson S, Brekkan A, Tulinius H.
Mass Screening for Breast Cancer.
Scand J Soc Med 1986;14:3-6.; Geirsson G, Kristjansdottir R, Sigurdsson K, Moss S, Tulinius H.
Cervical cancer screening in Iceland: A case-control study.
In: Hakama M, Miller AB, Day NE, Eds. Screening for cancer of the uterine cervix, IARC Scientific Publication, International Agency for Research on Cancer (IARC), Lyon, 1986, 76, p. 37-41.; Hakulinen T, Andersen AA, Malker B, Pukkala E, Schou G, Tulinius H.
Trends in Cancer Incidence in the Nordic Countries.
Acta Pathol Microbiol Immunol Scand Sect A 1986, 94.; Tulinius H.
Centralized Cancer Screening - its Transfer to Primary Health Care.
In: Wedel H, Siem H, (eds.) Prevention i Primärvården, Nordiska hälsovårdshögskolan, The Nordic School of Public Health, 1986, 1, p. 105-114.; ↑ Fara efst í listann
1985: Gislason I, Magnusson B, Tulinius H.
Malignant melanoma of the uvea in Iceland 1955-1979.
Acta Ophthalmologica 1985;63:389-94.; Jonasson JG, Jonasson F, Bjornsson A, Magnusson B.
Sortuæxli í táru á Íslandi. [Malignant melanoma of the conjunctiva in Iceland.]
Læknablaðið (Icelandic Medical J) 1985;71:282-284.; Jonasson JG, Magnusson B, Tulinius H, Bjornsson A.
Sortuæxli á Íslandi 1955-1984. [Melanoma in Iceland 1955-1984.]
Læknablaðið (Icelandic Medical J) 1985;71:274-81.; Rafnsson V, Johannesdottir SG, Oddsson H, Benediktsson H, Tulinius H, Magnusson G.
Dánarmein og nýgengi krabbameina hjá vélstjórum og mótorvélstjórum. [Mortality and cancer incidence of marine engineers and machinists in Iceland.]
Læknablaðið (Icelandic Medical J) 1985;71:226-32.; Tulinius H, Sigfusson N, Sigvaldason H, Day NE.
Can anthropometric and biochemical measurements illustrate the diet-cancer connection?
Näringsforskning 1985;29:17-22.; Tulinius H, Sigfusson N, Sigvaldason H, Day NE.
Relative Weight and Human Cancer Risk. In: Joosens JV, Hill MJ, Gebors J, (eds.).
Diet and Human Carcinogenesis, Proceedings of the 3rd ECP Symposium, Aarhus, Denmark, 19th-21st June, 1985, International Congress Series No 685. Amsterdam, Elsevier Science Publishers bv., 1985.; Tulinius H.
Familial Cancer Registration in Iceland.
In: Muller, Weber (eds.). Familial Cancer. 1st int. Res. Conf., Basel 1985, p. 263-267 (Karger, Basel 1985).; Tulinius H.
Familial Risk of Breast Cancer in Iceland.
In: Muller, Weber (eds.). Familial Cancer. 1st int. Res. Conf., Basel 1985, p. 25-26 (Karger, Basel 1985).; ↑ Fara efst í listann
1984: Gislason I, Magnusson B, Tulinius H.
Sortuæxli í æðahjúp augna á Íslandi 1955-1979. [Melanoma of uveae in Iceland 1955-1979.]
Læknablaðið (Icelandic Medical Journal) 1984;70:335-42.; Sigurdsson G, Einarsson I, Josafatsson JI, Magnusson G, Olafsson O, Sigvaldason H, Thorarinsson S, Tulinius H.
A Medical Record and Information System for Primary Health Care in Iceland. The Egilsstadir Project.
In.: Scand J Prim Health Care 1984;2:159-61.; Tulinius H, Geirsson G, Sigurdsson K, Day NE.
Screening for Cervix Cancer in Iceland.
In: McBrien DCH, Slater TF, (eds.) Cancer of the Uterine Cervix. Academic Press London, 1984, p. 55-76.; Tulinius H.
Late Determinants of Cancer.
Path. Res. Pract. 1984;179:74-80.; ↑ Fara efst í listann
1983: Bjarnason O, Tulinius H.
Cancer Registration in Iceland 1955-1974.
Icelandic Cancer Society Research Puplication No. 1. Acta Pathol Microbiol Scand Sect A, 1983, Suppl 281, p. 1-120.; Bjarnason O, Tulinius H.
Morphology Specific Incidence of Cancer of the Ovary in Iceland, 1955-1974.
In: Stalsberg, Helge, Ed. An International Survey of Distributions of Histologic Types of Tumours of the Testis and Ovary. UICC Technical Report Series, Volume 75. International Union Against Cancer, Geneva, 1983, p. 215-226.; Brekkan A, Kjartansson O, Tulinius H, Sigvaldason H.
Diagnostic Sensitivity of X-Ray Examination of the Large Bowel in Colorectal Cancer.
Gastrointest Radiol 1983;8:363-5.; Hallgrimsson J, Thorarinsson H, Tulinius H.
Tumours in Iceland. 7. Malignant Epithelial tumours of the Lung.
Acta Pathol Microbiol Immunol Scand Sect. A 1983;91:203-7.; Kjartansson O, Brekkan A, Tulinius H.
Röntgenrannsóknir á krabbameinum í ristli og endaþarmi. [X-ray diagnostic of cancer of colon and rectum.]
Læknablaðið (Icelandic Medical J) 1983;69:3-10.; Muir CS, Tulinius H, Nagy-Tiborcz A, Demaret E.
Knowledge "Lost" and "Latent". In: Köhler CO, Böhm K, Thome R, Eds. Aktuelle Methoden der Information in der Medizin.
Ecomed, Landsberg/Lech, 1983, p. 111-123.; Stalsberg H, Bjarnason O, de Carvalho ARL, Correa P, Czernobilsky B, Doctor, VM, Hwang WS, Misad O, Nathan P, Parker RGF, Salazar H, Sampat MB, Sasano N, Scully RE, Tulinius H, Wade-Evans T, Waterhouse JAH, Williams AO.
International Comparisons of Histologic Types of Ovarian Cancer in Cancer Registry Material. In: Stalsberg, Helge, Ed. An International Survey of Distributions of Histologic Types of Tumours of the Testis and Ovary.
UICC Technical Report Series, Volume 75. International Union Against Cancer, Geneva 1983, p. 247-280.; Tulinius H, Bjarnason O.
Krabbameinsskráning. [Cancer registration.]
Læknablaðið (Icelandic Medical J). 1983;69:363-70.; ↑ Fara efst í listann
1982: Geirsson G, Johannesson G, Tulinius H.
Tumours in Iceland. 5. Malignant Tumours of the Cervix Uteri. Histological Types, Clinical Stages and the Effect of Mass Screening.
Acta Pathol Microbiol Scand Sect. A 1982;90:139-43.; Johannesson G, Geirsson G, Day N, Tulinius H.
Screening for Cancer of the Uterine Cervix in Iceland 1965-1978.
In: Acta Obstet Gynecol Scand 1982;61,199-203.; Johannesson G, Geirsson G, Day NE, Tulinius H.
Mass screening for cervical cancer in Iceland 1965-1979, and the effect on incidence and mortality.
Cancer Detection and Prevention 1982;5:179-184.; Johannesson G, Geirsson G, Tulinius H.
Trends in Incidence in Iceland of the Cancer of the Uterine Cervix. Ed. Knut Magnus.
Hemisphere publishing corporation, 1982, p. 305-309.; Perry SB, Thorhallsson P, Hallgrimsson J.
Tumours in Iceland. 6. Tumours of the urinary bladder, ureter and urethra. A histological classification and some epidemiological and environmental factors.
Acta Pathol Microbiol Immunol Scand Sect A 1982;90:175-83.; Tulinius H, Day N, Bjarnason O, Geirsson G, Johannesson G, Conzales M, Sigvaldason H, Bjarnadottir G, Grimsdottir K.
Familial Breast Cancer in Iceland.
Int J Cancer 1982; 29:365-71.; Tulinius H, Sigvaldason H.
Trends in Incidence of Female Breast Cancer in the Nordic Countries. Trends in Cancer Incidence. Ed. Knut Magnus.
Hemisphere publishing corporation, 1982, p. 235-247.; Tulinius H.
Latent Malignancies.
In: Cancer Campaign, 6, Cancer Epidemiology. Gustav Fischer Verlag, Stuttgart, New York, 1982, p. 129-137.; ↑ Fara efst í listann
1981: Cooper MA, Hallgrimsson J.
Tumours in Iceland. 4. Tumour of the upper respiratory tract and ear. A histological classification and some etiological and epidemiological considerations.
Acta Pathol Microbiol Scand Sect A 1981;89:377-87.; Franssila K, Saxen E, Teppo L, Bjarnason O, Tulinius H, Normann T, Ringertz N.
Incidence of Different Morphological Types of Thyroid Cancer in the Nordic Countries.
Acta Pathol Microbiol Scand Sect. A, 1981;89:49-55.; Thorhallsson P, Tulinius H.
Tumours in Iceland. 3. Malignant Tumors of Kidney. A Histological Classification.
Acta Path Microbiol Scand Sect. A 1981;89:403-10.; Tulinius H, Sigvaldason H.
Cancer Incidence and Occupations in an Area of Low Air Pollution.
In: Banbury Report 9: Quantification of Occupational Cancer, Cold Spring Harbor Laboratory, 1981, p. 523-541.; ↑ Fara efst í listann
1980: Bjarnason O.
Possible environmental risk factors in the causation of thyroid cancer in Iceland.
In: Lag J (ed). Geomedical aspects in present and future research. 1980;133-7.; Geirsson G, Johannesson G, Tulinius H.
Histological types and clinical stages of cervical cancer in Iceland before and after the onset of mass screening.
Cancer Detection and Prevention 1980;3:379.; Gudmundsson OK.
Krabbamein í vélinda. [Cancer of the oesophagus.]
Læknablaðið (Icelandic Medical J) 1980;66:227-32.; Johannesson G, Geirsson G, Day NE, Tulinius.
Screening for cancer of the uterine cervix in Iceland 1965-1979, and the effect on incidence and mortality.
Cancer Detection and Prevention 1980;3:376.; Johannesson G.
Resultat av bröstcancer screening i Island. [Results of breast cancer screening in Iceland.]
In: Wallgren A et. al. eds. Tidigupptakt av bröstcancer. Stockholm: Riksforeningen mot cancer, 1980:153-7.; Sigurdsson G, Magnusson G, Sigvaldason H, Tulinius H, Einarsson I, Olafsson O.
Egilsstada-Projektet. Problemorienterad journal och individbaserat informationssystem för primärvård.
NOMESKO Nordisk Medicinal-Statistisk Kommitté, 1980, p. 1-197.; Sigurdsson G, Magnusson G, Sigvaldason H, Tulinius H, Einarsson I, Olafsson O.
Egilsstaðarannsóknin. Sjúkraskrár fyrir heilsugæslustöðvar og tölvufærsla upplýsinga. [A Medical Record and Information System for Primary Health Care in Iceland. The Egilsstadir Project.]
Heilbrigðisskýrslur (Public Health in Iceland), 1980, Supplement no. 1, p. 7-87.; Sigvaldason H, Tulinius H.
Human Health Data from Iceland. In: Cairns J, Lyon JL, Skolnick M. Cancer Incidence in Defined Populations, Cold Spring Harbor Laboratory.
Banbury Report 4, 1980, p. 257-265.; Tulinius H, Day NE, Sigvaldason H, Bjarnason O, Johannesson G, Gonzales M, Grimsdottir K, Bjarnadottir G.
A Population-based Study on Familial Aggregation of Breast Cancer in Iceland. Taking Account of some other Risk Factors. In: Gelboin HV, MacMahon B, Matsushima T, Sugimura T, Takayama S, Takebe H, eds. Genetic and Environmental Factors in Experimental and
Japan Scientific Societies press, 1980, p. 303-312.; Tulinius H.
Choice of Methods for Gathering Nutrition Information.
Nutrition and Cancer 1980;2,4:200-2.; Tulinius H.
Epidemiology of Breast Cancer, Mortality and Incidence.
In: Wallgren A et. al. (eds.) Tidigupptäckt av bröstcancer. Vetenskaplig symposium. Riksförening mot cancer. Stockholm 1980, p. 12-15.; Tulinius H.
Genetics and Epidemiology of Cancer of the Breast.
Nordic Council for Arctic Medical Research. Report no. 26, 1980, p. 113-116.; ↑ Fara efst í listann
1979: Hallgrimsson J, Tulinius H.
Chronic non-Rheumatic Aortic Valvular Diseases. A population Study based on Autopsies.
J Chron Disease 1979;32:355-63.; McKnight CK, Magnusson B.
Tumours in Iceland 1. Malignant tumours of the skin. A histological classification.
Acta Pathol Microbiol Scand Sect A 1979;87:37-44.; Sigurjonsson SV, Hallgrimsson J, Brekkan A.
Tumours in Iceland. 2. Tumours and tumour-like lesions of bone. Histological types and clinical course.
Acta Pathol Microbiol Scand Sect A 1979;87:403-9.; Tulinius H.
Epidemiology of Gastric Cancer.
Nutrition and Cancer 1979;1:61-9.; ↑ Fara efst í listann
1978: Day NE, Muenz L, Tulinius H.
Some Aspects of Familial Breast Cancer. In: Grundman, E. & Beck, L. eds. Early Diagnoses of Breast Cancer.
Cancer Campaign. Gustav Fisher Verlag, Stuttgart/New York 1978, 1, p. 29-36.; Johannesson G, Geirsson G, Day N.
The effect of mass screening in Iceland, 1965-1974, on the incidence and mortality of cervical carcinoma.
Int J Cancer 1978;21:418-25.; Saxen E, Franssila K, Bjarnason O, Normann T, Ringertz N.
Observer variation in histologic classification of thyroid cancer.
Acta Pathol Microbiol Scand Sect A 1978 Nov;86(6):483-6.; Tulinius H, Bjarnason O.
Morphology Specific Incidence of Breast Cancer in Iceland 1968-1973.
In: Correa, P. & Johnson, W. D. eds. An International Survey of Distributions of Histologic Types of Cancer. UICC Technical Report Series 1978, 35, p. 195-203.; Tulinius H, Day NE, Johannesson G, Bjarnason O, Gonzales M.
Reproductive Factors and Risk for Breast Cancer.
Int J Cancer 1978;21:724-730.; Tulinius H, Sigvaldason H.
Aldursstöðlun [Age Standardization.]
Læknablaðið (Icelandic Medical J) 1978;64:133-6.; Tulinius H.
Epidemiology of Gastric Cancer.
In: Marabou Food & Cancer. Suppl. 16. Näringsforskning 1978;22:53-63.; ↑ Fara efst í listann
1977: Breslow N, Chan CW, Dhom G, Drury RAB, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H.
Latent Carcinoma of Prostate at Autopsy in Seven Areas. Collaborative Study Organized by the International Agency for Research on Cancer. Lyons, France.
Int J Cancer 1977;20:680-8.; Tulinius H.
Epidemiology of Prostate Carcinoma.
In: Grundman, E. & Vahlensieck, W. eds. Tumors of the Male Genital System. Recent Results in Cancer Research. Springer Verlag. Heidelberg, 1977, 60, p. 3-13.; Tulinius H.
Zur Epidemiologie der Nicht-Hodgkins Lymphome.
Strahlentherapie, 1977;153,209-17.; Williams ED, Doniach I, Bjarnason O, Michie W.
Thyroid cancer in an iodide rich area: a histopathological study.
Cancer. 1977 Jan;39(1):215-22.; ↑ Fara efst í listann
1976: Bjarnason O. Iceland. In: Waterhouse J, Muir C, Correa P, Powel J (eds.):
Cancer Incidence in Five Continents. Vol III.
Lyon: IARC, 1976;320-3.; Thorarinsson H.
Krabbamein í ristli og endaþarmi. [Colorectal cancer.]
Læknablaðið (Icelandic Medical J) 1976;62:185-95.; ↑ Fara efst í listann
1975: Bjarnason O, Magnusson M.
Linkage of the Icelandic Cancer Registry to an Icelandic population file.
Recent Results Cancer 1975;50:90-7.; ↑ Fara efst í listann
1974: Bjarnason O, Day N, Snædal G, Tulinius H.
The Effect of Year of Birth on the Breast Cancer Age-Incidence Curve in Iceland.
Int J Cancer 1974;13:689-96.; Thorarinsson A, Jensson O, Bjarnason O.
Krabbameinsleit hjá konum 1964-1970. [Cancer screening among women 1964-1970.]
Læknablaðið (Icelandic Medical J) 1974;60:121-128; Tulinius H.
Geographical distribution of malignant neoplasms and some other epidemiological features.
In: Handbuch der Allgemeinen Patologie. VI. 5. Berlin-Heidelberg-New York, Springer, 1974:417-60; ↑ Fara efst í listann
1973: Bjarnason O, Bjarnason V, Edwards JH, Fridriksson S, Magnusson M, Mourant EE, Tills D.
The blood groups of Icelanders.
Ann Hum Genet 1973;36:425-58.; Hallgrimsson J.
Lung tumours in Iceland.
Acta Pathol Microbiol Scand Sect A 1973;81:813-23.; ↑ Fara efst í listann
1972: Arnason A, Bjarnason O.
Post mortem changes of human serum esterases. An electropheric study.
Acta Pathol Microbiol Scand 1972;80A:841-6.; Bjarnason O.
Ovarian tumours in Iceland.
Acta Pathol Microbiol Scand Sect A. 1972;233:87-90.; ↑ Fara efst í listann
1971: Bjarnason O.
Cancer incidence in Finland, Iceland, Norway and Sweden. A cooperative sudy.
Acta Pathol Microbiol Scand. Sect A 1971;79(suppl 224):1-95.; ↑ Fara efst í listann
1970: Gudmundsson KR.
A survey of tumours of the central nervous system in Iceland during the 10-year period 1954-1963.
Acta Neurol Scand 1970;46:538-52.; Thorarinsson H, Hallgrimsson J.
Histological typing of carcinoma of lung in Iceland.
Acta Pathol Microbiol Scand Sect A 1970, (suppl) 215.; ↑ Fara efst í listann
1969: Sigurjonsson J.
Athuganir á tíðni magakrabbameins. [Survey of the incidence of stomach cancer.]
Læknablaðið (Icelandic Medical J) 1969;55:117-27.; Thorarinsson A, Jensson O, Bjarnason O.
Screening for uterine cancer in Iceland.
Acta Cytol. 1969 May; 13(5):304-8.; Thorarinsson H.
Carcinoma of the lung in Iceland.
Scand J Thoracic Cardiovasc Surg 1969;3:31-8.; ↑ Fara efst í listann
1967: Bjarnason O.
Cancer incidence in Iceland. In: Shivas AA (ed.). Racial and Geographical Factors in Tumour Incidence.
Pfizer Medical Monographs 2, Edinburgh: University Press, 1967;117-31.; Dungal N, Sigurjonsson J.
Gastric cancer and diet. A pilot study on dietary habits in two districts differing markedly in respect of mortality from gastric cancer.
Br J Cancer. 1967 Jun;21(2):270-6.; Hallgrimsson S.
Krabbamein í colon og rectum. [Colorectal cancer.]
Læknablaðið (Icelandic Medical J) 1968;54:153-66.; Johannesson G.
Krabbamein í leghálsi. [Cervix cancer.]
Læknablaðið (Icelandic Medical J) 1968;54:189-208.; Sigurjonsson J.
Occupational variations in mortality from gastric cancer in relation to dietary differences.
Br J Cancer. 1967;21:651-6.; Sigurjonsson J.
Causes of death in old age.
Geriatrics 1968;23:152-7.; Thorarinsson A, Jensson O, Bjarnason O.
Masseundersögelser med henblik på collum cancer. [A mass survey of the incidence of cervix cancer.]
Nord Med 1967;78:1608-11.; Thorarinsson H, Hallgrimsson J, Bjarnason O, Petersen G.
Carcinoma of the lung in Iceland.
Dis Chest. 1967 Dec;52(6):754-9.; Thorarinsson H, Hallgrimsson J, Bjarnason O, Petersen GF.
Lungnakrabbamein á Íslandi 1931-1964. [Lung cancer in Iceland 1931-1964.]
Læknablaðið (Icelandic Medical J) 1967;53:68-78.; Thorsteinsson T, Thordarsson G.
Polycyclic hydrocarbons in singed food in Iceland.
Cancer 1968;21:390-2.; Thorsteinsson T.
Polycyclic hydrocarbons in commercially and home smoked food in Iceland.
Cancer 1968;23:455-7.; ↑ Fara efst í listann
1966: Bjarnason O.
Iceland. In: Doll R, Payne P, Waterhouse J (eds.): Cancer Incidence in Five Continents.
Berlin: UICC/ Springer, 1966.; Dungal N.
Stomach cancer in Iceland.
Proc Can Cancer Conf 1966;6:441-9; Sigurjonsson J.
Geographical variation in mortality from cancer in Iceland, with particular reference to stomach cancer.
J Natl Cancer Inst 1966;37:337-46.; ↑ Fara efst í listann
1964: Armstrong RW.
Spectrographic analyses of pasture grass and drinking water in relation to stomach cancer mortality in Iceland.
Acta Agriculturae Scand 1964;XIV:65-76.; Snædal G.
Cancer of the breast. A clinical study of treated and untreated patients in Iceland 1911-1955. Thesis.
Acta Chir Scand 1964;Suppl 338:1-100.; ↑ Fara efst í listann
1963: Bjarnason O.
Uterine carcinoma in Iceland.
Thesis. From the Department of Pathology, University of Iceland, Reykjavik 1963.; Snaedal G.
Brjóstakrabbamein á Íslandi. Sögulegt yfirlit og safn íslenskra heimilda um krabbamein frá upphafi til 1910. [Breast cancer in Iceland. History and collection of Icelandic references on cancer upto 1910.]
Heilbrigðisskýrslur 1959 (Public Health in Iceland 1959.) Reykjavík, 1963:161-84.; Wynder EL, Kmet J, Dungal N, Segi M.
An epidemiological investigation of gastric cancer.
Cancer 1963;16:1461-96.; ↑ Fara efst í listann
1962: Thorarinsson H.
Krabbamein í lungum. [Lung cancer.]
Læknablaðið (Icelandic Medical J) 1962;46:79-93.; Thorgeirsson T, Bjarnason O.
Magakrabbamein í aðsendum sýnishornum 1951-1960. [Cancer diagnosed in stomach biopsies.]
Læknablaðið (Icelandic Medical J) 1962;46:126-31.; ↑ Fara efst í listann
1961: Dungal N.
Can smoked food be carcinogenic?
Acta Unio Int contre le Cancerum 1961;17:365-6.; Dungal N.
Lung cancer in Iceland.
Lancet 1961;ii:1350.; Dungal N.
The special problems of stomach cancer in Iceland. With particular reference to dietary factors.
JAMA 1961;178:789-98.; ↑ Fara efst í listann
1959: Dungal N.
The carcinogenic elements of smoked foods.
Krebsartzt 1959;14(1):22-24.; Petersen GF.
Cancer of the lung in Iceland.
Acta Radiol 1959;188:200-9.; ↑ Fara efst í listann
1958: Bailey EJ, Dungal N.
Polycyclic hydrocarbons in Icelandic smoked food.
Br J Cancer 1958;12:348-50.; Dungal N, Benediktsson T.
Gastric cancer and atherosclerosis.
Lancet 1958;i:931-2.; Dungal N, Hansen H.
Peptic ulcers in Iceland.
Schweiz Z Pathol Bakteriol 1958;21:225-8.; Dungal N.
Cancer in Iceland.
In: Raven RW (ed.): Cancer. London: Butterworth, 1958; 3:262-71.; ↑ Fara efst í listann
1957: Bjarnason O.
Frumuflagnsrannsóknir. [Exfoliative cytology.]
Læknablaðið (Icelandic Medical J). 1957;41:2-14.; Jacobsson PHJ.
Chorionepithelioma.
Læknablaðið (Icelandic Medical J) 1957;41:163-75.; ↑ Fara efst í listann
1956: Dungal N.
Search for gastro-intestinal cancer with fecal tests.
Acta Unio Int Contra Cancerum 1956;12:53-6.; ↑ Fara efst í listann
1955: Dungal N.
Cancer in Iceland.
Ann R Coll Surg Engl 1955;16:211-26.; Dungal N.
Cancer in Iceland with special reference to stomach cancer.
Schweitz Z Pathol Bakteriol 1955;18:550-6.; ↑ Fara efst í listann

Útgefið vísindaefni varðandi krabbamein ... tengt Krabbameinsskránni

Útgefið vísindaefni varðandi krabbamein
... tengt Krabbameinsskránni